Diabetes Care Community Learn, connect and care
In June 2014, the United States Food and Drug Administration (FDA) approved the inhaled insulin called Afrezza for use in the treatment of type 1 diabetes.
Read More »In June 2014, the United States Food and Drug Administration (FDA) approved the inhaled insulin called Afrezza for use in the treatment of type 1 diabetes.
Read More »